PA14378
UBIAD1 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PA14378-Each-of-1 | In Stock | ₹ 46,502.50 |
PA14378 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
UBIAD1
Classification
Polyclonal
Conjugate
Unconjugated
Gene
UBIAD1
Gene Alias
1200002M06Rik; AI426463; AW320947; RGD1309588; RP4-796F18.1; SCCD; Tere1; transitional epithelia response protein; transitional epithelial response protein 1; UbiA prenyltransferase domain containing 1; ubiA prenyltransferase domain-containing protein 1; UBIAD1
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
29914
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
Western Blot
Concentration
1 mg/mL
Formulation
PBS with 0.02% sodium azide
Gene Accession No.
Q9Y5Z9
Gene Symbols
UBIAD1
Immunogen
Synthetic peptide corresponding to residues P(32) E Q D R L P Q R S W R Q K(45) of human TERE1.
Quantity
100 μg
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- PA1-4378 detects the TERE1 protein in human samples
- PA1-4378 has been successfully used in Western blot procedures
- By Western blot this antibody detects a ∽37 kDa protein representing TERE1 in urothelial carcinoma
- The PA1- 4378 immunogen is a synthetic peptide corresponding to residues P(32) E Q D R L P Q R S W R Q K(45) of human TERE1
- There is 85% sequence identity to mouse and rat
- A novel gene designated TERE1, has a significant effect on the growth regulation in bladder cancer
- The TERE1 gene maps to a chromosome locus that has been identified by loss of heterozygosity studies as a site of a putative tumor suppressor gene or genes for multiple tumor types including prostate carcinoma
- Data suggest that TERE1 may be significant in prostate cancer growth regulation and the down regulation or absence of TERE1 may be an important component of the phenotype of advanced disease
- Data also suggest a potential role for this gene product in the progression of bladder cancer.